IPCA Laboratories Limited
Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)
What IPCA files
- Others46
- Investor Meet26
- Important21
- Board Meeting11
- Updates9
- Dividend/Bonus8
Ipca Labs Q1 FY27 results show strong performance. Consolidated revenue grew 21% year-on-year to INR2,788 crores, with EBITDA margins expanding significantly to 22.88% (up 4.49 percentage points). Domestic formulations rose 13%, exports 34%, and API business 30%. Management increased FY27 growth outlook to 14-16% and consolidated EBITDA margin guidance to...
Ipca Laboratories Limited held a conference call to discuss the Company’s Q1FY27 earnings and business update. The audio link for the call is available on the company's shareholders' information page.
IPCA Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
IPCA Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 13, 2026. Further, the company has informed the Exchange regarding voting results.
IPCA Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 13, 2026